Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0QL9W
|
|||
| Former ID |
DIB016142
|
|||
| Drug Name |
Quadrivalent pediatric combination vaccine
|
|||
| Synonyms |
DD-687; Quadrivalent pediatric combination vaccine (pertussis, tetanus, diphtheria and polio); DTaP-IPV, Sanofi Pasteur/Daiichi Sankyo/sanofi-aventis/Kitasato Institute; Quadrivalent pediatric combination vaccine (pertussis, tetanus, diphtheria and polio), Sanofi Pasteur/Daiichi Sankyo/Sanofi/Kitasato Institute; Quadrivalent pediatric combination vaccine (pertussis, tetanus, diphtheria and polio), Sanofi Pasteur/Daiichi Sankyo/sanofi-aventis/Kitasato Institute
Click to Show/Hide
|
|||
| Indication | Bordetella pertussis infection [ICD-11: 1C12.0; ICD-10: A37.0] | Registered | [1] | |
| Company |
Sanofi Pasteur-Daiichi Sankyo Vaccines Co Ltd
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800029525) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.